PPARA and diabetes mellitus: To determine the therapeutic effects of APS treatment on cardiac dysfunction in lipotoxic cardiomyopathy with or without diabetes, echocardiography was performed on both db/db mice and MHC-PPARα mice with or without APS treatment.